{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidsaahe32d5pgdoejuc43b7saqgvc7ffhion42vapbfhw36n6wygi",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mndo7skpcx32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih2ste24oa3rgfijw5blvvglgtt74pwxswbvj5756e75r3eqigzey"
    },
    "mimeType": "image/jpeg",
    "size": 326930
  },
  "path": "/goodbye-cpap-new-pill-shows-major-promise-for-sleep-apnea/",
  "publishedAt": "2026-06-02T14:27:19.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "American Thoracic Society",
    "Medicine",
    "Sleep Apnea",
    "Sleep Science"
  ],
  "textContent": "A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep apnea by targeting the biological mechanisms that cause airway collapse during sleep. A once-nightly pill significantly improved obstructive sleep apnea (OSA) symptoms in a large phase 3 clinical trial presented at the 2026 ATS International Conference. [...]",
  "title": "Goodbye CPAP? New Pill Shows Major Promise for Sleep Apnea"
}